A carregar...
Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)‐6 produced during remission phase
T helper type 17 (Th17) cytokines have been implicated in the pathogenesis of neuromyelitis optica (NMO). As humanized anti‐interleukin (IL)‐6R (tocilizumab) immunoglobulin (Ig)G has been used as disease‐modifying therapy for NMO, the objective of our study was to investigate the role of endogenous...
Na minha lista:
| Publicado no: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750605/ https://ncbi.nlm.nih.gov/pubmed/26472479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12733 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|